-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on QuidelOrtho, Lowers Price Target to $61

Benzinga·02/13/2025 16:57:16
Listen to the news
RBC Capital analyst Conor McNamara maintains QuidelOrtho (NASDAQ:QDEL) with a Outperform and lowers the price target from $64 to $61.